InsidersTradesSigma
Total declarations
Companies
▲ Purchases (3 ops.)
▼ Sales (29 ops.)
Insider track record
Board DirectorDisclosed buys
3
Disclosed sells
29
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the full record of transactions filed by Pendarvis David, Independent Director. Officer active across 3 companies, notably RESMED INC. Cumulatively, 47 reports have been recorded. Breakdown: 3 buys · 29 sells. Total volume traded: €8.6m. Activity tracked since 3 May 2021. The latest transaction was filed on 5 February 2026 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Companies and markets linked to Pendarvis David
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations47 total
424 shares@ US$247.1535.6% of flowCommon StockSEC:0000105132-26-000011:0
Canonical exit: 6 May 2026 (T+90)
612 sharesCommon StockSEC:0000105132-25-000123:0
523 shares@ US$196.3755.2% of flowCommon StockSEC:0000105132-25-000093:0
Canonical exit: 28 Jan 2026 (T+90)
412 sharesCommon StockSEC:0000105132-24-000111:0
328 shares@ US$234.75100.0% of flowCommon StockSEC:0000105132-24-000027:0
Canonical exit: 11 Jul 2024 (T+90)
406 sharesCommon StockSEC:0000105132-23-000103:0
1,500 shares@ US$219.791.5% of flowResMed Common StockSEC:0001127602-23-018089:0
1,500 shares@ US$237.641.6% of flowResMed Common StockSEC:0001127602-23-014596:0
1,500 shares@ US$218.231.5% of flowResMed Common StockSEC:0001127602-23-012530:0
1,500 shares@ US$216.691.5% of flowResMed Common StockSEC:0001127602-23-009228:0
1,500 shares@ US$224.501.5% of flowResMed Common StockSEC:0001127602-23-003509:0
1,500 shares@ US$210.071.5% of flowResMed Common StockSEC:0001127602-23-000789:0
840 sharesCommon StockSEC:0001567619-22-021646:0
1,500 shares@ US$229.811.6% of flowResMed Common StockSEC:0001127602-22-026963:0
683 shares@ US$146.340.5% of flowResMed Common StockSEC:0001127602-22-026463:0
12,389 shares0ResMed Common StockSEC:0001127602-22-026352:0
450 shares@ US$225.180.5% of flowResMed Common StockSEC:0001127602-22-025655:0
1,545 shares@ US$215.231.7% of flowResMed Common StockSEC:0001127602-22-024941:0
1,545 shares@ US$220.191.7% of flowResMed Common StockSEC:0001127602-22-023624:0
1,545 shares@ US$216.921.7% of flowResMed Common StockSEC:0001127602-22-022156:0
1,683 shares0ResMed Common StockSEC:0001127602-22-021424:0
1,545 shares@ US$240.721.8% of flowResMed Common StockSEC:0001127602-22-020493:0
1,545 shares@ US$212.331.6% of flowResMed Common StockSEC:0001127602-22-019009:0
1,545 shares@ US$209.440.0008% mcap1.9% of flowResMed Common StockSEC:0001127602-22-016949:0
1,545 shares@ US$200.000.0008% mcap1.8% of flowResMed Common StockSEC:0001127602-22-013220:0
25 of 47 declarations
About Pendarvis David
PENDARVIS DAVID is an Independent Director. He has 47 filings in total. Across the 47 sampled filings, the transactions run from 2016-01-05 to 2026-02-06, with EUR 249085 of purchases and EUR 8362916 of sales, and the most frequent transaction nature is Cession. The recent filings concern RESMED INC, WD 40 CO and SEQUENOM INC, with notable individual amounts published on 2021-11-18, 2022-08-04, 2021-09-07, 2021-12-06, 2022-01-04 and 2021-11-15.
